 |
 |
|
Bio-Buzz No.7 / 2006
IN THIS ISSUE - HEADLINE NEWS - INDUSTRY CORNER - EDITORIAL
HEADLINE NEWS BioApproaches South West National Business promotion - October 2006 event 24th October 2006, Osborne & Clarke building, Bristol Continuing from the success of the Spring Astra Zeneca Event, BioApproaches SW is launching a new Big Pharma business promotional network opportunity. Dr Andrew Wood, Executive Director, Global External Research & Development (Eli Lilly) has kindly offered to give a presentation discussing the global market from the perspective of Eli Lilly and Company Limited. Through the day Dr Wood is timetabled to discuss business development and partnership opportunities with Eli Lilly, BioApproaches is managing the schedule. A central period of the day will allow for networking along with some key industry and academic presentations. Dr Wood is keen to engage with companies with products (at any stage of development) in specific fields of interest related to Eli Lilly. In brief he mentioned looking at new pharmaceuticals or biomarkers concerning;- Neuroscience; Metabolic; Cardiovascular; Oncology and 'Whitespace'(i.e. urology; rheumatology; asthma and specialist patient care systems). Note, Medical devices or diagnostics are not an immediate interest of Eli apart from where they can be used to investigate new platforms for drug discovery Drug Discovery strategies, markets and commercial opportunties
- Sponsored by BioApproaches SW
INDUSTRY CORNER - Vectura Group plc announces the successful outcome of a Phase II "proof-of concept " clinical study for its inhaled product, VR040, for the treatment of induced "off" periods in patients with Parkinson's disease. More info HERE - BIA board - nominations for AGM to take effect January 2007 - Nominations are currently being sought for the members of the board of the BIA to be elected at the AGM on 10 October, for a period of two years from 1 January 2007. There are likely to be 4 vacancies for corporate members and one for associate members. For more info please contact Andrew Hodges, ahodges@bioindustry.org T: 0207 565 7168 - The DTI have published the 2004 statistics from Critical I , and these are available their website HERE In parallel, the BIA have commissioned a commentary on the statistics from Critical I Ltd. They are making the executive summary publicly available, and this is on their website HERE BUSINESS DEVELOPMENT & FUNDING - UK technologies for biomarkers mission to the USA: Boston 25 - 27 September 2006 - call for "expressions of interest" UK Trade & Investment is seeking companies with technologies for biomarkers and molecular diagnostics to participate in a mission to the US September 25 - 27th. To find out more information and register for the trade mission, please contact: Mina Joshi: E: mina.joshi@uktibiotech.org.uk T: +44 (0)7793874984 - deadline for applying to participate in this mission is this Friday, August 25. -BEER & PARTNERS LIMITED - In the period from 1 January to 31 July 2006 they have:- accepted 69 clients (down slightly on 2005); . Added 183 new investors ; . Successfully arranged equity finance for 32 clients through business angel contacts (nearly double last year's figure); . Raised £10.7 million (again nearly double last year). The average is about a third of a million. For further details contact Malcolm McGregor, SW Regional Director, E-mail T: 01823 667972 - Autumn 2006 and Spring 2007 Collaborative R&D competitions
- Applied Research call by the Carbon Trust, which is open to UK businesses and research institutions. The call opens on 16th October and closes on 6th December more info HERE
Biomass for local heat or electricity generation is among the priorities, but there may be other areas of interest to you more info HERE
A grant of up to £250K is available, but subject to a minimum of 40% matched funding. - DTI announce new focus for the next round of funding opportunities for high technology programmes and Bio is high on the list. For more information click HERE
TGN1412: Joint Industry Taskforce produces guidelines to improve conduct of early stage clinical trials.
-'DIY Guide to the Successful Exploitation of Intellectual Property and Market Research' - A free summary guide (PDF) is now available from Evolution Life Sciences Ltd. Other available free downloads for include: Investor criteria for spin-out investment; Spin-out journey map.W: www.evolutionlifescience.com
EDITORIAL BioApproaches SW and dotmatics have teamed-up to provide discounts to BioApproaches SW members - a free trail and discounts on licenses for its products including eye, gateway and browser. eye "Billions of concepts, millions of documents, many sources; one interface" The aim of eye is to aggregate all scientific information in a single, easy to use interface. Scientists and analysts can run a query against millions of documents from pre-compiled and updated sources. eye uses an intelligent search technology that 'knows' what terms mean so you no longer need to enter multiple meanings for terms or use complex Boolean logic. The combination of the built in analytical indexing approach and aggregation of huge amounts of data means that any entity, whether it is a document, person, drug or organisation can be searched and analysed. 10% discount on list price for BioApproaches members! eyeforscience - Access eye from dotmatics web servers through annual subscription at 33% discount - single seat license for £2k instead of the normal £3k gateway "Changing the way people work" gateway has literally changed the way people work in organisations using it. gateway was originally built and refined over 6 years for a major pharmaceutical company where it saved millions of dollars by making users share and find more information more efficiently. The tool is now used by large and small companies alike and is even in use at a leading UK University. 10% discount on list price for BioApproaches members! browser "Bringing all relevant scientific information to a scientist's desktop" browser makes searching and reporting on complex chemical and biological data easy and fast. With its unique indexing mechanism not only is it the fasted query and browsing tool, it is also the most flexible. Users can visualise data in almost any way imaginable, from forms, tables, pivots, 2D and 3D plots, bar-charts and advanced plots. Existing customers found it so powerful they replaced any existing tools from the existing world's leaders in this area. 10% discount on list price for BioApproaches members Free trials of these applications are available on request. For more information please visit the dotmatics website HERE or view a brochure HERE
Contact Us For further information on any of these items, please visit our website: www.bioapproaches.co.uk or contact us directly. Jade Fulbrook-Smith - BioBuzz Editor Dr Pauline Lee, Network Manager
|
You are currently subscribed to Bio-Buzz as %%emailaddr%%. To unsubscribe from this list, send a blank email to this address. |
